相关实验视频

Updated: Sep 12, 2025

Genome Engineering of Primary Human B Cells Using CRISPR/Cas9

Genome Engineering of Primary Human B Cells Using CRISPR/Cas9

Published on: November 3, 2020

工程B细胞用于治疗和研究人类疾病

Nikita Trivedi¹, Ragan A Pitner¹, David J Rawlings^1,2

¹Seattle Children's Research Institute, Center for Immunity and Immunotherapy, Seattle, WA, USA.

Nature biotechnology

|August 6, 2025

概括

工程B细胞 (eB细胞) 疗法利用独特的B细胞特性治疗疾病. 早期的临床试验显示出有希望的结果,目前正在进行的研究正在探索癌症和慢性疾病的未来应用.

科学领域:

免疫学免疫学免疫学
细胞疗法细胞疗法
生物技术是生物技术.

背景情况:

B细胞具有独特的免疫特征,如细胞间通信,蛋白质生产和寿命.
这些特征正在被用于新的治疗策略.
工程B细胞 (eB细胞) 疗法代表了再生医学的新兴前沿.

研究的目的:

审查工程B细胞 (eB细胞) 疗法的最新进展.
总结早期的临床发现,并讨论挑战.
探索基于B细胞的治疗方法的未来方向.

主要方法:

审查最近的科学文献和早期临床试验数据.
分析B细胞生物学及其在治疗工程中的应用.
讨论基因组编辑和动物建模的进展.

主要成果:

在研究EB细胞和进行概念验证研究方面取得了重大进展.
启动第一批EB细胞疗法的临床试验.
确定临床实施的关键挑战和有希望的途径.

结论:

工程B细胞疗法具有治疗复杂疾病的巨大潜力.
克服临床实施挑战对于广泛采用至关重要.
预计未来将在瘤学和慢性疾病管理领域应用.

更多相关视频

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

相关概念视频

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...